Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Verily, a precision health company founded in 2015 and based in South San Francisco, California, operates at the intersection of healthcare and technology. Formerly known as Google Life Sciences, Verily leverages data science, artificial intelligence, and cloud-based analytics to accelerate clinical research and enable more personalized care. The company has raised a total of $3.5 billion in funding, indicating significant investor interest in its innovative approach to healthcare solutions.
As a subsidiary of Alphabet Inc., Verily has been making strides in the healthcare industry with its advanced technological solutions. However, despite its growth and potential, there is currently no concrete information available regarding Verily's IPO prospects. The company has not made any official announcements about going public, and we have not found any recent news or reports discussing potential IPO plans.
It's important to note that the decision to go public involves various factors, including market conditions, company readiness, and strategic objectives. For investors interested in the potential of buying Verily stock or investing in Verily shares, it's advisable to keep an eye on official announcements from the company or its parent organization, Alphabet Inc., for any updates on future plans.
As the healthcare technology sector continues to evolve, Verily's innovative approach and strong financial backing position it as a company to watch. However, without official information or credible reports about IPO plans, any discussion about Verily's potential stock offering or ticker symbol remains speculative at this time.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Verily's IPO prospects remain uncertain, investors eager to gain exposure to innovative healthcare technology companies don't have to wait. At Linqto, we offer members access to interests in pre-IPO private companies, including potential leaders in the health tech sector. Our platform allows you to diversify your portfolio with lower minimum investments in promising companies like Verily, potentially benefiting from their growth before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
